ARID1A and endometriosis: Furthermore, in these five MSI-H cases, no correlations were found between the MSI-H and clinicopathological factors including age, FIGO stage, initial treatment, status of residual tumor, status of ARID1A expression, and the status of endometriosis (Table 1).